van der Wel JWT, Jebbink M, van den Broek D, Steinbusch LC, et al. Combined analysis of circulating tumor DNA and tumor tissue to overcome osimertinib resistance (OSIRIS); the second line osimertinib cohort. Lung Cancer 2024;198:107972.
PMID: 39556978